Novara Therapeutics Limited
Company profile
DissolvedUnited Kingdom
Financial position
Accounts to 2024-03-31 · GBP
Net assets
−£28,818
Cash
—
Turnover
—
Profit / loss
—
Current assets
£198
Creditors < 1 year
—
Equity
—
Average employees
0
Balance-sheet trend
GBP · unknownTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
| Balance sheet | ||||
| Net assets | −£28,818 | −£26,934 | −£25,154 | −£11,475 |
| Assets | ||||
| Current assets | £198 | £198 | £100 | £100 |
| Debtors | £198 | £198 | £100 | £100 |
| Liabilities | ||||
| Creditors | £29,016 | £27,132 | £25,254 | £11,575 |
| Net current assets | −£28,818 | −£26,934 | −£25,154 | −£11,475 |
| Assets less current liabilities | −£28,818 | −£26,934 | −£25,154 | −£11,475 |
| People | ||||
| Average employees | 0 | 0 | 0 | 0 |
| Source evidence | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesRegister status requires review: Dissolved.
No charges available in our records.